22.418 articles found

Neurotrophic factors for the treatment of Parkinson's disease.

Chiocco MJ, Harvey BK, Wang Y, Hoffer BJ.

Parkinsonism Relat Disord · 2007-01-01

DOI: 10.1016/s1353-8020(08)70024-5PMID: 18267258

Treatment of dementia associated with Parkinson's disease.

Emre M.

Parkinsonism Relat Disord · 2007-01-01

DOI: 10.1016/s1353-8020(08)70049-xPMID: 18267283

Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point.

Bartus RT, Herzog CD, Bishop K, Ostrove JM, Tuszynski M, Kordower JH, Gasmi M.

Parkinsonism Relat Disord · 2007-01-01

DOI: 10.1016/s1353-8020(08)70052-xPMID: 18267286

Impact of physical therapy for Parkinson's disease: a critical review of the literature.

Kwakkel G, de Goede CJ, van Wegen EE.

Parkinsonism Relat Disord · 2007-01-01

DOI: 10.1016/s1353-8020(08)70053-1PMID: 18267287

Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Kabanov AV, Gendelman HE.

Prog Polym Sci · 2007-01-01

DOI: 10.1016/j.progpolymsci.2007.05.014PMID: 20234846

[Communication disorders marked with hypophonia. Indication and speech therapy through the LSVT method].

Cabaret P, Sarfati J.

Rev Laryngol Otol Rhinol (Bord) · 2007-01-01

PMID: 20387379

Daytime somnolence and night sleep disturbances in Parkinson's disease: background and future treatment prospective.

Antonini A.

Neurol Sci · 2007-01-01

DOI: 10.1007/s10072-007-0732-1PMID: 17235433

Prevalence and treatment of non-motor symptoms in Parkinson's disease.

Sullivan KL, Ward CL, Hauser RA, Zesiewicz TA.

Parkinsonism Relat Disord · 2006-12-26

DOI: 10.1016/j.parkreldis.2006.10.008PMID: 17188922

TREATMENT OF SYNUCLEINOPATHIES

JUSTMAN Craig J., LANSBURY Peter T. Jr., ROSENBERG Adam J., WILLIAMS Peter J..

· 2006-12-22

USE OF PI3K ACTIVITY AGONIST COMPOUNDS IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS, THE RESULTING PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF IN THE TREATMENT OF DISEASES

FERRUS GAMERO ALBERTO, MARTIN PENA ALFONSO, ACEBES VINDEL ANGEL, RODRIGUEZ SANCHEZ JOSE RODRIGO, FERNANDEZ FUNEZ PEDRO.

· 2006-12-22

Treatment of Synucleinopathies

JUSTMAN CRAIG J, LANSBURY PETER T.JR, ROSENBERG ADAM J, WILLIAMS PETER J.

· 2006-12-22

The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias.

Kuan WL, Lin R, Tyers P, Barker RA.

Neurobiol Dis · 2006-12-22

DOI: 10.1016/j.nbd.2006.11.001PMID: 17188499